Delcath Systems Appoints Vojislav Vukovic As Chief Medical Officer

Jun 20, 2023•about 2 years ago

Position

Chief Medical Officer

Company

Delcath Systems

Vojo Vukovic

New YorkBiotechnology

Description

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Vojislav \"Vojo\" Vukovic as its new Chief Medical Officer .

Company Information

Company

Delcath Systems

Location

1633 BROADWAY

New York, New York, United States

About

Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Delcath Systems Appoints Vojislav Vukovic As Chief Medical Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Executive Insights

Related People

Sandra hidden

Martha hidden

Vojo hidden

Company Information